Skip to main content

UBS Group AG

Position in LH — Labcorp Holdings Inc.

CIK 1610520 ZURICH, V8

Position in LH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$144,499,600
-$6,122,381 QoQ
Shares Held
516,070
-8.6% QoQ
Ownership
0.636%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#37
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 62% Shared 0% None 38%

Common Shares in LH Over Time

Shares Held

Position Value (USD)

Derivatives in LH

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$57,412
PutShares
200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,535,472,160 across 44 Diagnostics & Research names. LH ranks #13 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LH

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $144,499,600 516,070
2026-03-31 $150,621,981 564,529
2025-12-31 $124,319,818 495,535
2025-09-30 $139,232,422 485,029
2025-09-30 $57,412 200
2025-06-30 $130,580,347 497,430
2025-06-30 $52,502 200
2025-03-31 $46,548 200
2025-03-31 $102,787,291 441,640
2024-12-31 $88,912,407 387,722
2024-09-30 $81,866,082 366,324
2024-06-30 $3,073,001 15,100
2024-06-30 $78,147,634 383,999